Clarity on Comparative Effectiveness: How and When it Will be Used by Payers
Watch On-Demand. Recorded January 2010.
Gain insight on how comparative effectiveness may be rolled out in the United States, how it will differ from models in Europe and Canada, and what other utilization management initiatives may be on the horizon.
Bob Mauch discusses how payers continue to influence the pharmaceutical market and what pharma can do to ensure continued product success and patient access to medications.
Specifically, we will explore:
- Comparative effectiveness here vs similar programs in other countries
-
Comparative effectiveness questions raised by patients and physicians
-
How the healthcare industry is addressing questions about patient access
-
Other utilization management strategies gaining traction among payers
This webisode is part of “In the Know,” a twice-monthly dose of thought leadership developed by AmerisourceBergen Specialty Group. "In the Know" uses a rapid-fire, Q&A format to deliver the insights that matter most -- all in less than 15 minutes per webisode. Learn more and view other webisodes at knowledgedriven.com.
